These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7759608)

  • 1. In vivo preferential usage of TCR V beta 8 in Torpedo acetylcholine receptor immune response in the murine experimental model of myasthenia gravis.
    Aimé-Sempé C; Cohen-Kaminsky S; Bruand C; Klingel-Schmitt I; Truffault F; Berrih-Aknin S
    J Neuroimmunol; 1995 May; 58(2):191-200. PubMed ID: 7759608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis.
    Pierce JL; Zborowski KA; Kraig E; Infante AJ
    Int Immunol; 1994 May; 6(5):775-83. PubMed ID: 8080845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
    J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
    Wu B; Shenoy M; Goluszko E; Kaul R; Christadoss P
    J Immunol; 1995 Apr; 154(7):3603-10. PubMed ID: 7897239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
    Yang B; McIntosh KR; Drachman DB
    Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice.
    Karachunski PI; Ostlie N; Bellone M; Infante AJ; Conti-Fine BM
    Scand J Immunol; 1995 Aug; 42(2):215-25. PubMed ID: 7631155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
    Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
    J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
    Kaul R; Wu B; Goluszko E; Deng C; Dedhia V; Nabozny GH; David CS; Rimm IJ; Shenoy M; Haqqi TM; Christadoss P
    J Immunol; 1997 Jun; 158(12):6006-12. PubMed ID: 9190955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
    Loutrari H; Tzartos SJ; Claudio T
    Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VH gene family utilization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; Verschuuren JJ; Bos NA; van Breda Vriesman PJ; De Baets MH
    J Neuroimmunol; 1993 Mar; 43(1-2):113-24. PubMed ID: 8458983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P; Lindstrom J; Talal N
    Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis.
    Dedhia V; Goluszko E; Wu B; Deng C; Christadoss P
    Clin Immunol Immunopathol; 1998 Jun; 87(3):266-75. PubMed ID: 9646836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor V beta 15 dominates the antiacetylcholine receptor response in Lewis rat T cell lines.
    Smith LR; Kono DH; Asthana D; Balderas RS; Fujii Y; Lindstrom J; Theofilopoulos AN
    J Immunol; 1994 Mar; 152(5):2596-600. PubMed ID: 8133067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V beta-specific immunotoxin selectively kills acetylcholine receptor-reactive T lymphocytes from mice with experimental autoimmune myasthenia gravis.
    Thompson PA; McAtee R; Infante AJ; Currier P; Beninati W; Krolick KA
    Int Immunol; 1994 Dec; 6(12):1807-15. PubMed ID: 7696201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor-specific CD4+ T cells in myasthenia gravis patients have individual, but restricted TCR V beta usage.
    Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
    Ann N Y Acad Sci; 1998 May; 841():324-8. PubMed ID: 9668251
    [No Abstract]   [Full Text] [Related]  

  • 17. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides.
    Pachner AR; Kantor FS; Mulac-Jericevic B; Atassi MZ
    Immunol Lett; 1989 Feb; 20(3):199-204. PubMed ID: 2469649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.
    Lobito AA; Yang B; Lopes MF; Miagkov A; Adams RN; Palardy GR; Johnson MM; McFarland HI; Recher M; Drachman DB; Lenardo MJ
    Eur J Immunol; 2002 Jul; 32(7):2055-67. PubMed ID: 12115627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Qiao J; Olsson T; Huang WX
    J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.